Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

TRMLTRML
7 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in TOURMALINE BIO INC

Bank of New York Mellon Corp previously held 0 shares of TRML (TOURMALINE BIO INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$909,164

Total Shares Change

-70,697

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%
0
2025-Q3
Decreased
49,964
-11.8%
$2.4M0.0%
0
2025-Q2
Decreased
56,671
-6.7%
$906,1690.0%
0
2025-Q1
Decreased
60,720
-0.9%
$923,5510.0%
0
2024-Q4
Decreased
61,259
-0.3%
$1.2M0.0%
0
2024-Q3
Decreased
61,438
-13.1%
$1.6M0.0%
0
2024-Q2
New
70,697
-
$909,1640.0%
34

Other major holders of TRML: Avoro Capital Advisors LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used